Biocryst Pharmaceuticals, Inc. · NASDAQ:BCRX
State Street Corp reported a 5.30% stake in Biocryst Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 9, 2026
State Street Corp reported a 5.30% stake in Biocryst Pharmaceuticals, Inc., 11,073,211 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 11,073,211
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.30% | 11,073,211 |
Source
Related
- Biocryst Pharmaceuticals, Inc.
- State Street Corp
- Biocryst Pharmaceuticals, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · State Street Corp · May 12, 2026
- Form 4 · Stonehouse Jon P · Sep 2, 2026
- Form 4 · Milne Jill C. · Sep 2, 2026
- Form 4 · Milano Vincent · Sep 2, 2026
- Form 4 · McKee Amy E · Sep 2, 2026
- Form 4 · Frank Steven · Sep 2, 2026